TCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 28, 2014
TCL Archive LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter. October 17, 2008